Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
暂无分享，去创建一个
M. Landray | J. Emberson | C. Baigent | J. Neuberger | I. Macdougall | P. Harden | P. Friend | N. Sheerin | P. Gibbs | A. Sharif | M. Akyol | R. Haynes | S. Bhandari | R. Pararajasingam | P. Chowdhury | D. Lewis | K. Rigg | C. Watson | W. Herrington | P. Rowe | C. Newstead | N. Krishnan | S. Sinha | M. Clancy | A. Baxter | A. Asderakis | Gareth L. Jones | C. Puliatti | M. Lay | A. Hammad | Chidambaram Nathan | Kathy Jayne